Report Detail
Global Artificial Pancreas Devices Systems Market Insights, Forecast to 2025
- RnM2470921 |
- 30 April, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
The global Artificial Pancreas Devices Systems market is valued at 56 million US$ in 2018 and will reach 140 million US$ by the end of 2025, growing at a CAGR of 12.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Artificial Pancreas Devices Systems market based on company, product type, end user and key regions.
This report studies the global market size of Artificial Pancreas Devices Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Artificial Pancreas Devices Systems in these regions.
This research report categorizes the global Artificial Pancreas Devices Systems market by top players/brands, region, type and end user. This report also studies the global Artificial Pancreas Devices Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Market size by Product
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Market size by End User
Hospitals
Clinics
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Artificial Pancreas Devices Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Artificial Pancreas Devices Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Artificial Pancreas Devices Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Artificial Pancreas Devices Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Artificial Pancreas Devices Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Artificial Pancreas Devices Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Artificial Pancreas Devices Systems Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Artificial Pancreas Devices Systems Market Size Growth Rate by Product
- 1.4.2 Threshold Suspended Device Systems
- 1.4.3 Hybrid Closed-loop APDS
- 1.4.4 Other Systems
- 1.5 Market by End User
- 1.5.1 Global Artificial Pancreas Devices Systems Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Artificial Pancreas Devices Systems Market Size
- 2.1.1 Global Artificial Pancreas Devices Systems Revenue 2014-2025
- 2.1.2 Global Artificial Pancreas Devices Systems Sales 2014-2025
- 2.2 Artificial Pancreas Devices Systems Growth Rate by Regions
- 2.2.1 Global Artificial Pancreas Devices Systems Sales by Regions
- 2.2.2 Global Artificial Pancreas Devices Systems Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Artificial Pancreas Devices Systems Sales by Manufacturers
- 3.1.1 Artificial Pancreas Devices Systems Sales by Manufacturers
- 3.1.2 Artificial Pancreas Devices Systems Sales Market Share by Manufacturers
- 3.1.3 Global Artificial Pancreas Devices Systems Market Concentration Ratio (CR5 and HHI)
- 3.2 Artificial Pancreas Devices Systems Revenue by Manufacturers
- 3.2.1 Artificial Pancreas Devices Systems Revenue by Manufacturers (2014-2019)
- 3.2.2 Artificial Pancreas Devices Systems Revenue Share by Manufacturers (2014-2019)
- 3.3 Artificial Pancreas Devices Systems Price by Manufacturers
- 3.4 Artificial Pancreas Devices Systems Manufacturing Base Distribution, Product Types
- 3.4.1 Artificial Pancreas Devices Systems Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Artificial Pancreas Devices Systems Product Type
- 3.4.3 Date of International Manufacturers Enter into Artificial Pancreas Devices Systems Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Artificial Pancreas Devices Systems Sales by Product
- 4.2 Global Artificial Pancreas Devices Systems Revenue by Product
- 4.3 Artificial Pancreas Devices Systems Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Artificial Pancreas Devices Systems Breakdown Data by End User
6 North America
- 6.1 North America Artificial Pancreas Devices Systems by Countries
- 6.1.1 North America Artificial Pancreas Devices Systems Sales by Countries
- 6.1.2 North America Artificial Pancreas Devices Systems Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Artificial Pancreas Devices Systems by Product
- 6.3 North America Artificial Pancreas Devices Systems by End User
7 Europe
- 7.1 Europe Artificial Pancreas Devices Systems by Countries
- 7.1.1 Europe Artificial Pancreas Devices Systems Sales by Countries
- 7.1.2 Europe Artificial Pancreas Devices Systems Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Artificial Pancreas Devices Systems by Product
- 7.3 Europe Artificial Pancreas Devices Systems by End User
8 Asia Pacific
- 8.1 Asia Pacific Artificial Pancreas Devices Systems by Countries
- 8.1.1 Asia Pacific Artificial Pancreas Devices Systems Sales by Countries
- 8.1.2 Asia Pacific Artificial Pancreas Devices Systems Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Artificial Pancreas Devices Systems by Product
- 8.3 Asia Pacific Artificial Pancreas Devices Systems by End User
9 Central & South America
- 9.1 Central & South America Artificial Pancreas Devices Systems by Countries
- 9.1.1 Central & South America Artificial Pancreas Devices Systems Sales by Countries
- 9.1.2 Central & South America Artificial Pancreas Devices Systems Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Artificial Pancreas Devices Systems by Product
- 9.3 Central & South America Artificial Pancreas Devices Systems by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Artificial Pancreas Devices Systems by Countries
- 10.1.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Countries
- 10.1.2 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Artificial Pancreas Devices Systems by Product
- 10.3 Middle East and Africa Artificial Pancreas Devices Systems by End User
11 Company Profiles
- 11.1 Medtronic
- 11.1.1 Medtronic Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Medtronic Artificial Pancreas Devices Systems Products Offered
- 11.1.5 Medtronic Recent Development
- 11.2 Bigfoot Biomedical
- 11.2.1 Bigfoot Biomedical Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Products Offered
- 11.2.5 Bigfoot Biomedical Recent Development
- 11.3 Beta Bionics
- 11.3.1 Beta Bionics Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Beta Bionics Artificial Pancreas Devices Systems Products Offered
- 11.3.5 Beta Bionics Recent Development
- 11.4 Admetsys
- 11.4.1 Admetsys Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Admetsys Artificial Pancreas Devices Systems Products Offered
- 11.4.5 Admetsys Recent Development
- 11.5 Insulet
- 11.5.1 Insulet Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Insulet Artificial Pancreas Devices Systems Products Offered
- 11.5.5 Insulet Recent Development
- 11.6 Tandem Diabetes Care
- 11.6.1 Tandem Diabetes Care Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Products Offered
- 11.6.5 Tandem Diabetes Care Recent Development
- 11.7 Defymed
- 11.7.1 Defymed Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Defymed Artificial Pancreas Devices Systems Products Offered
- 11.7.5 Defymed Recent Development
12 Future Forecast
- 12.1 Artificial Pancreas Devices Systems Market Forecast by Regions
- 12.1.1 Global Artificial Pancreas Devices Systems Sales Forecast by Regions 2019-2025
- 12.1.2 Global Artificial Pancreas Devices Systems Revenue Forecast by Regions 2019-2025
- 12.2 Artificial Pancreas Devices Systems Market Forecast by Product
- 12.2.1 Global Artificial Pancreas Devices Systems Sales Forecast by Product 2019-2025
- 12.2.2 Global Artificial Pancreas Devices Systems Revenue Forecast by Product 2019-2025
- 12.3 Artificial Pancreas Devices Systems Market Forecast by End User
- 12.4 North America Artificial Pancreas Devices Systems Forecast
- 12.5 Europe Artificial Pancreas Devices Systems Forecast
- 12.6 Asia Pacific Artificial Pancreas Devices Systems Forecast
- 12.7 Central & South America Artificial Pancreas Devices Systems Forecast
- 12.8 Middle East and Africa Artificial Pancreas Devices Systems Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Artificial Pancreas Devices Systems Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Artificial Pancreas Devices Systems . Industry analysis & Market Report on Artificial Pancreas Devices Systems is a syndicated market report, published as Global Artificial Pancreas Devices Systems Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Artificial Pancreas Devices Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
